探索代谢物功能对心力衰竭和冠心病的影响:从孟德尔随机化 (MR) 研究的见解
Vicheth Virak1, Pengkhun Nov2, Deshu Chen1
1Department of Cardiology, Laboratory of Heart Center, Zhujiang Hospital, Southern Medical University Guangzhou, Guangdong, The People's Republic of China.
American journal of cardiovascular disease
|September 23, 2024
概括
代谢功能影响心力衰竭 (HF) 和冠心病 (CHD). 特定的代谢物,如和g-glutamyl glycine,以及不平衡的比例,增加心血管风险,需要进一步的机制研究.
科学领域:
- 心血管疾病流行病学
- 代谢学 代谢学 代谢学
- 遗传流行病学遗传流行病学
背景情况:
- 心力衰竭 (HF) 和冠心病 (CHD) 是全球领先的健康负担.
- 传统的风险因素已得到充分研究,但代谢物功能在心血管疾病 (CVD) 发展中的作用仍然不太清楚.
- 门德尔随机化 (MR) 为研究代谢物和心血管疾病之间的因果关系提供了一种强有力的方法.
研究的目的:
- 研究代谢物功能对心力衰竭 (HF) 和冠心病 (CHD) 风险的因果关系.
- 确定与这些心血管疾病风险增加相关的特定代谢表型.
主要方法:
- 使用孟德尔的随机化 (MR) 方法来评估因果关系.
- 使用与代谢物水平相关的遗传变异作为工具变量.
- 综合了来自各种大型队列和GWAS的综合遗传和表型数据.
主要成果:
- 在61名被评估者中,确定了10种影响HF和CHD风险的显著代谢细胞表型.
- 发现提升的排泄物 (22:1n9),提升的g-glutamyl glycine和提升的7-methylguanine增加了风险.
- 观察到较低的α-托科菲罗尔和不平衡的素与甲基因因比率与心血管风险增加有关.
- 结果在所有人群中一致,并且对灵敏度分析具有稳定性.
结论:
- 这项MR研究提供了强有力的证据,证明了特定代谢物功能对HF和CHD的影响.
- 突出了某些代谢物的潜力,作为心血管疾病的新风险因素.
- 对潜在机制的进一步研究对于开发有针对性的治疗策略至关重要.
更多相关视频
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
3.3K
03:42Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
Published on: March 29, 2024
1.4K
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
396
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
396
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:22Heart Failure Drugs: β-Blockers
320
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
320
01:22Heart Failure Drugs: Diuretics
349
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
349
01:29Pathophysiology of Cardiac Performance
601
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
601
01:26Heart Failure Drugs: Inotropic Agents
539
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
539